Terns Pharmaceuticals Inc (TERN) — Financial Flexibility Index
Terns Pharmaceuticals Inc (TERN) has a Financial Flexibility Index of -1.12x as of September 2025. Free cash flow of $-19.77 Million (operating CF $-19.77 Million minus capex $0.00) represents -1% of total liabilities ($17.59 Million). Check Terns Pharmaceuticals Inc (TERN) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Terns Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Terns Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Terns Pharmaceuticals Inc.
Annual Financial Flexibility Index for Terns Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Terns Pharmaceuticals Inc. Explore TERN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.87x | $-69.97 Million | $-70.02 Million | $18.06 Million | ▲ +24.3% |
| 2023 | -5.12x | $-67.34 Million | $-67.39 Million | $13.15 Million | ▼ -5.7% |
| 2022 | -4.84x | $-48.83 Million | $-49.11 Million | $10.08 Million | ▲ +9.3% |
| 2021 | -5.34x | $-41.49 Million | $-41.83 Million | $7.77 Million | ▼ -333.1% |
| 2020 | -1.23x | $-29.23 Million | $-29.81 Million | $23.70 Million | ▲ +89.5% |
| 2019 | -11.71x | $-65.32 Million | $-66.22 Million | $5.58 Million | ▼ -1006.0% |
| 2018 | -1.06x | $-17.83 Million | $-18.07 Million | $16.84 Million | — |